|
⚲
|
| Keyboard |
| Lenz Robert A
✚
|
|
|---|---|
| CIK # | 0001992908 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001992908] | |
| 4 | [0001992908] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lenz Robert A | |
| LB Pharmaceuticals Inc | |
| NovaBridge Biosciences | |
| Neumora Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
LB Pharmaceuticals Inc LBRX
Stock Option (Right to Buy) · derivative
|
2026-03-06 | Grant | 20,000 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2025-02-18 | Sell | 5,614 | $1.67 | 9,375 |
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Grant | 502,934 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Grant | 100,000 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Disposed to issuer | 502,934 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Disposed to issuer | 100,000 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2024-10-10 | Sell | 8,260 | $15.09 | 124,643 |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2024-10-09 | Sell | 5,563 | $15.01 | 83,501 |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2024-09-18 | Sell | 10,676 | $12.09 | 129,073 |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2024-09-17 | Sell | 30,788 | $11.81 | 363,606 |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2024-09-12 | Sell | 32,948 | $11.43 | 376,596 |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2024-02-14 | Grant | 50,000 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2024-02-14 | Grant | 100,000 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2023-09-14 | Grant | 502,934 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-09-14 | Grant | 352,941 | $0.00 |